Technical Analysis for PSTI - Pluristem Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 3.2 -1.54% -0.05
PSTI closed down 1.54 percent on Thursday, November 14, 2019, on 79 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical PSTI trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
Stochastic Reached Oversold Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -1.54%
Volume Surge Other -1.54%
New 52 Week Low Weakness -1.54%
180 Bearish Setup Bearish Swing Setup -2.74%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.74%

Older signals for PSTI ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Pluristem Therapeutics Inc., a bio-therapeutics company, engages in the research, development, and commercialization of standardized cell therapy products and related technologies for the treatment of life threatening diseases. The company's products are derived from human placenta that is a non-controversial, non-embryonic, and adult cell source. Its Placental adherent stromal cells are grown in the company's proprietary PluriX three-dimensional process that allows cells to grow in a natural environment. The company develops placenta expanded cells (PLX) and peripheral artery disease cells, an allogeneic therapeutic product that is in Phase-II clinical trials for the treatment of intermittent claudication, critical limb ischemia, and Buerger's disease. Its PLX product is developed for the treatment of muscle injury, bone marrow diseases, inflammatory bowel disease, and multiple sclerosis, as well as for pulmonary disorders, acute radiation syndrome, acute myocardial infarction, diabetic diastolic heart failure, neuropathic pain, inflammatory bowel disease, multiple sclerosis, and ischemic stroke for which the product is in various pre-clinical trials. Pluristem Therapeutics Inc. is also involved in the development and commercialization of a PLX cell-based product for the treatment of pulmonary arterial hypertension through its license agreement with the United Therapeutics Corporation. The company was formerly known as Pluristem Life Systems Inc. and changed its name to Pluristem Therapeutics Inc. in November 2007. Pluristem Therapeutics Inc. was founded in 2001 and is headquartered in Haifa, Israel.
Biotechnology Life Sciences Biology Diseases Pain Stem Cells Radiation Multiple Sclerosis Inflammatory Bowel Disease Pulmonary Arterial Hypertension Cell Therapy Peripheral Artery Disease Acute Myocardial Infarction Ischemic Stroke
Is PSTI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.9
52 Week Low 3.17
Average Volume 47,320
200-Day Moving Average 6.0283
50-Day Moving Average 3.7249
20-Day Moving Average 3.4354
10-Day Moving Average 3.3417
Average True Range 0.1825
ADX 12.79
+DI 13.6714
-DI 21.532
Chandelier Exit (Long, 3 ATRs ) 3.4425
Chandelier Exit (Short, 3 ATRs ) 3.7175
Upper Bollinger Band 3.7356
Lower Bollinger Band 3.1352
Percent B (%b) 0.11
BandWidth 17.476859
MACD Line -0.126
MACD Signal Line -0.1219
MACD Histogram -0.0041
Fundamentals Value
Market Cap 311.91 Million
Num Shares 97.5 Million
EPS -0.32
Price-to-Earnings (P/E) Ratio -10.00
Price-to-Sales 0.00
Price-to-Book 6.15
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.41
Resistance 3 (R3) 3.42 3.37 3.38
Resistance 2 (R2) 3.37 3.31 3.36 3.36
Resistance 1 (R1) 3.28 3.28 3.26 3.27 3.35
Pivot Point 3.23 3.23 3.21 3.22 3.23
Support 1 (S1) 3.14 3.17 3.12 3.13 3.05
Support 2 (S2) 3.09 3.14 3.08 3.04
Support 3 (S3) 3.00 3.09 3.03
Support 4 (S4) 2.99